Literature DB >> 31966504

MicroRNA-21 promotes endometrial carcinoma proliferation and invasion by targeting PTEN.

Wenrong Zhao1, Peng Geng2, Yunyun Li1, Xiaohe Wei1, Jingxin Cheng1.   

Abstract

Endometrial carcinoma is one of the most common gynecological malignant tumors. Recent evidence has demonstrated that miR-21 is involved in the proliferation and invasion of endometrial carcinoma. This study aims to explore the effect of biological behavior of miR-21 on endometrial carcinoma its relationship with PTEN. First, Collected endometrial carcinoma and adjacent non-tumor issues, the relative expression levels of miR-21 and PTEN mRNA were quantitated by real-time polymerase chain reaction (RT-PCR). Next, endometrial carcinoma cell line Ishikawa were transfected with miR-21 inhibitor. After transfection, real-time PCR was used to detect the expression levels of miR-21. Then, the cells proliferation, the apoptotic rates and the invasion rates were detected by MTT method, flow cytometry, and Transwell assay. The expression levels of p-PTEN and PTEN proteins were detected by western blot. The results showed that miR-21 was significantly up-regulation and PTEN was down-regulation in endometrial carcinoma tissues (P < 0.05). miR-21 inhibitor were successfully transfected into Ishikawa cell. The cell proliferation activity, and the number invasion cells in the miR-21 inhibitor group was obviously lower than the miR-21 NC group and Normal group (P < 0.05). The apoptosis rate in the miR-21 inhibitor group was significantly higher than the miR-21 NC group and Normal group (P < 0.05). The expression levels of p-PTEN in miR-21 inhibitor groups were significantly higher than miR-21 NC group and Normal group (P < 0.05). Therefore, we concluded that miR-21 could promote cell proliferation and invasion ability, and inhibite cell apoptosis in endometrial carcinoma partially by regulating its target gene PTEN on post-transcriptional level. In brief, miR-21 may be a new early diagnosis mark and therapy target in endometrial carcinoma. IJCEP
Copyright © 2017.

Entities:  

Keywords:  Endometrial carcinoma; PTEN; apoptosis; invasion; miR-21; proliferation

Year:  2017        PMID: 31966504      PMCID: PMC6966072     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  3 in total

1.  MicroRNA-21 expression in cancer cells is an independent biomarker of progression-free survival of endometrioid endometrial carcinoma.

Authors:  Kimiya Sato; Morikazu Miyamoto; Masashi Takano; Hitoshi Tsuda
Journal:  Virchows Arch       Date:  2021-07-31       Impact factor: 4.064

2.  The Circadian Gene NPAS2 Act as a Putative Tumor Stimulative Factor for Uterine Corpus Endometrial Carcinoma.

Authors:  Xiaojiao Zheng; Xiuyi Lv; Linyan Zhu; Kejun Xu; Cong Shi; Lining Cui; Huiqing Ding
Journal:  Cancer Manag Res       Date:  2021-12-22       Impact factor: 3.989

Review 3.  Exosomes on Endometrial Cancer: A Biomarkers Treasure Trove?

Authors:  Alexandros G Sykaras; Konstantinos Christofidis; Ekaterini Politi; Stamatios Theocharis
Journal:  Cancers (Basel)       Date:  2022-03-29       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.